Human bone marrow stromal cells lose immunosuppressive and anti-inflammatory properties upon oncogenic transformation.
about
Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations.Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcomaTrabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma ModelsDetailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model.Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell FunctionBone microenvironment signals in osteosarcoma development.Prospective isolation of resident adult human mesenchymal stem cell population from multiple organs.Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenaseMesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications.FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway.Notch signaling pathway and gene expression profiles during early in vitro differentiation of liver-derived mesenchymal stromal cells to osteoblasts.IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AMLSoft Tissue Sarcoma Cancer Stem Cells: An Overview
P2860
Q27342050-300FAF25-C4A2-4047-BC5F-74A5A6F5B644Q28597747-39A02F9D-EF1B-425B-B9C8-85E2EC8B9AB4Q33649056-5E49CA4F-FF5B-4B52-BC59-A09E87FA2DACQ33795203-B6900C3A-1EAC-4EB8-BC08-3076DD21B383Q36668099-FA317A30-F6DC-4ADB-8545-2D29AE72F0ADQ37637831-713A821A-E89E-40F1-A0FE-8DF740C4941FQ38454980-CD6C7B5A-7576-4E51-86CA-EC55A2A5EDFBQ38671636-AB02AC21-9ED3-48EF-BBB6-3B0FD95BAEF5Q39804300-199CBE25-6A54-4B35-94E5-9C84ED613768Q41695046-E0CE9045-18E0-4857-8FA3-E513680B3D81Q47391013-C0F24B7E-1FE9-49CF-A550-8FF55CB806A7Q47956518-B114DA5B-E55E-4649-9492-4884864C6D88Q57927278-0FE42E6A-6C91-4D6A-8EF3-25D7F84214AFQ58707604-B9259D29-3823-4D61-8095-42F48424F3CC
P2860
Human bone marrow stromal cells lose immunosuppressive and anti-inflammatory properties upon oncogenic transformation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Human bone marrow stromal cell ...... upon oncogenic transformation.
@en
type
label
Human bone marrow stromal cell ...... upon oncogenic transformation.
@en
prefLabel
Human bone marrow stromal cell ...... upon oncogenic transformation.
@en
P2860
P50
P1433
P1476
Human bone marrow stromal cell ...... upon oncogenic transformation.
@en
P2093
Angélica Horrillo
Michael Rosu-Myles
P2860
P304
P356
10.1016/J.STEMCR.2014.08.005
P577
2014-09-11T00:00:00Z